FDA Inspection 1250905 - Haider Afzal, M.D. - October 04, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Haider Afzal, M.D., with an inspection on October 4, 2024, issued by the Dallas District Office, covering human drugs.

Company: Haider Afzal, M.D.
Inspection Date: October 4, 2024
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · c8a59d7f-73ab-4cdb-b8a4-95d91ec0b74b

Violation Codes2

21 CFR 312.6021 CFR 312.62(a)

Full citation text and observation details available on the Dashboard.